01244.HK
3D Medicines Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 2.61
+3.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.04x
- Price / sales
- 1.52x
- Price / cash flow
- -3.12x
Enterprise value
- Enterprise value
- HKD 314.1M
- EV / sales
- 0.75x
- EV / EBITDA
- -1.60x
- EV / EBIT
- -3.30x
- Market cap
- HKD 640.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026